HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process
Anne Vincent‐Salomon(Université Paris Sciences et Lettres), Xavier Sastre‐Garau(Institut Curie)
Cited by 114
Related Papers
MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis
|Cell stem cell|2014|178
Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French Multicentre GEFPICS* Study
|Histopathology|2003|121
Mature Cytotoxic CD56bright/CD16 <i>+</i> Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic Melanoma
|Cancer Research|2013|93
Pentraxin-3 is a PI3K signaling target that promotes stem cell–like traits in basal-like breast cancers
|Science Signaling|2017|52
Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer
|Cell Reports|2016|45